DE EN Anmelden

In your studies 'Drug Regulator Affairs'

©Volker Lannert / Universität Bonn

Master's thesis


As part of the continuing education Master's degree programme, Master's theses are written on relevant topics in the field of 'Drug Regulatory Affairs' using scientific methods. The topics are highly topical, diverse and the results are both of interest in a scientific context and relevant to many areas of activity in 'Drug Regulatory Affairs'.

Here you will find all Master's theses written since the year 2000, including the title and a summary. In this collection, many Master's theses can also be viewed and downloaded in full text.

Further information on Master's theses (e.g. registration, processing) can be found in our ‘Master's thesis guidelines/Leitfaden für die Anfertigung einer Masterarbeit’ (in German) and in the ‘Information leaflet - Master's thesis’ at

Downloads from A-Z

Do you have any questions or are you interested in the full text of a Master's thesis that is not listed here?
Please feel free to contact me.

Dr. Jasmin Fahnenstich

Dr. Jasmin Fahnenstich

Study programme manager

Phone: +49 (0) 228 - 9268 6806

Send e-mail

Master's thesis

The collection of Master's theses can be searched and sorted by entering keywords.

Year Name Title Full text Summary
2006 Dr. Manfred Kurz Registration of antibody based medicinal products ***
2006 Dr. Katrin Mayer Maintenance / life cycle management of a MRP-product – A case study ***
2006 Dr. Roger Müller-Pfaff Einführung des Hämaphereseverfahrens in den Blutspendedienst der Bundeswehr ***
2006 Kristina Mumber Regulatory Environment for medicinal products in Russian Federation
2006 Dr. Christiane Pering „Regulatory framework for the marketing authorisation of medicinal products for human use containing or consisting of genetically modified organisms – comparison of requirements in Europe and the United States“
2006 Gabriele Schäfer Regulatory assessment of registration processes for biosimilar products- Conditions to be fulfilled to use special registration procedures designed by different decision matrices ***
2006 Dr. Folker Spitzenberger Vigilance experience for high risk in vitro diagnostics: Risk assessment by the German competent authority and possible implications for the parties involved in the European medical devices system ***
2006 Dr. med. vet. Flurina Stucki New approaches and requirements in the registration procedure of MUMS-veterinary medicinal products. A comparison between USA, EU and Switzerland
2006 Annika Weyand Global Generic Business: Regulatory oriented Analysis of Development versus Licensing ***
2006 Dr. Astrid Weyermann Labelling requirements for investigational medicinal products in multinational studies: bureaucratic cost driver or added value? ***
2006 Renzo Wolbold The regulatory environment and requirements for biological and biotechnology-derived medicinal products in Japan
2005 Stefanie Abt Generic applications after implementation of the new EU pharmaceutical legislation: Criteria for the choice of the Marketing Authorisation Procedure
2005 Josefine Bauer Plasma Master File - A Concept for Plasma-derived Medicinal Products
2005 Dr. Barbara Blumbach Comparison of the regulatory environment for herbal medicinal products in the three ICH regions: EU, US and Japan
2005 Katrin Dürr Comparison of marketing authorisations procedures for biotechnological products in the European Union and in Switzerland ***
2005 Xenia Freifrau von Maltzan A CTD FOR ASEAN –- The Harmonisation of Regulatory Aspects in the ASEAN region
2005 Dr. Miriam Gensler Generic medicines –Quo vadis essential similarity? ***
2005 Dr. Susanne Gluding Chemical and Toxicological Qualification of Plastic Packaging Materials for Sterile Solutions ***
2005 Dr. Rudolf Gmeinbauer Decentralised Procedure, Mutual Recognition Procedure and Readability of SPC, PL, Labelling
2005 Dr. Joachim Gramberg Über die Abgrenzungsproblematik bei Repellents ***
  • Total: 969